Abstract

 

Depression and type 2 diabetes - Is there a common ground?
findings from The Maastricht Study

Depression risk is doubled in persons with type 2 diabetes. This has a large impact on quality of life and societal costs. Moreover, all cause and cardiovascular mortality is increased by 40%. There may be a common ground behind the co-occurrence of these disease, potential mechanisms include psychosocial, lifestyle and biomedical factors. The Maastricht Study is a rich resource for studying this common ground, due to its’ deep phenotyping approach on both diabetes, depression and brain imaging. This presentation, will highlight the research into the relation between diabetes and depression within The Maastricht Study over the past years.

Bio

Miranda Scham is Professor of population-based research into chronic diseases and founder and board member of The Maastricht Study, at the department of Internal Medicine. Her research interests focus on the pathophysiology of common chronic diseases, specifically type 2 diabetes and the link between psychosocial, medical and biological functioning, which she studies in population-based cohorts and many consortia (co-chair of Diabetes Pearl String lnitiative and SocNet4Health consortium, Netherlands Consortium of Dementia Cohorts (NCDC); DepressD and European Depression in Diabetes (EDID) consortia). Dr. Schram acquired multiple grants for the execution of The Maastricht Study (e.g. from Province of Limburg, European Fund of Regional Development, Stichting De Weijerhorst). Dr. Schram is the founder and chair of Netherlands Cohorts Consortium. She holds a MSc in biomedical sciences and epidemiology.